3 years ago

Preoperative Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers: Do We Have Enough “VISION” to Stop It?

London, M. J.
(Abstracted from Anesthesiology, 126(1):1–3, 2017) There is significant controversy regarding administration of angiotensin-converting enzyme inhibitors (ACEIs) as well as angiotensin II receptor blockers (ARBs). This editorial comments on the study by Roshanov et al1 (“Withholding Versus Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort”), which examined the large multinational, prospective Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) trial to assess risk-adjusted associations of ACEI/ARB administration versus withholding the drugs within the 24 hours preceding noncardiac surgery.
You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.